A DNA vaccine targeting FAP attenuated expression of proangiogenic factors such as VEGF, PDGFR and GM-CSF and suppressed angiogenesis and lymphangiogenesis in a 4T1 breast cancer model [80]. The gene discussed is FAP; the disease is breast cancer.